SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000913275-99-000003
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
7
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 179677
2 FIRST AMENDMENT TO JOINT VENTURE AGREEMENT DATED AS OF EX-10.8.1 3942
3 TECHNOLOGY LICENSE AND DEVELOPMENT AGREEMENT BETWEEN THE EX-10.12 36882
4 FIRST AMENDMENT TO TECHNOLOGY LICENSE AND DEVELOPMENT AGREEMENT EX-10.12.1 8722
5 SUBSIDIARY OF THE COMPANY EX-21.1 194
6 CONSENT OF ERNST & YOUNG, LLP EX-23.1 789
7 ARTICLE 5 FIN. DATA SCHEDULE FOR 10-K EX-27.0 2654
  Complete submission text file 0000913275-99-000003.txt   235225
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-22570 | Film No.: 99581474
SIC: 2833 Medicinal Chemicals & Botanical Products